| Gene symbol | HSPB1 | Synonyms | CMT2F, HEL-S-102, HMN2B, HMND3, HS.76067, HSP27, HSP28, Hsp25, SRP27 | Type of gene | protein-coding |
| Chromosome | 7 | Map location | 7q11.23 | dbXrefs | |
| Description | heat shock protein family B (small) member 1 | ||||
| GTO ID | GTC1524 |
| Trial ID | NCT02423590 |
| Disease | Lung Squamous Cell Carcinoma |
| Altered gene | Hsp27 |
| Therapeutic/Target gene | Target gene |
| Therapy | ASO |
| Treatment | OGX-427|Apatorsen |
| Co-treatment | Gemcitabine|Carboplatin |
| Phase | Phase2 |
| Recruitment status | Unknown |
| Title | A Phase II Randomised, Open-label Study of Gemcitabine/Carboplatin First-line Chemotherapy in Combination With or Without the Antisense Oligonucleotide Apatorsen (OGX-427) in Advanced Squamous Cell Lung Cancers |
| Year | 2014 |
| Country | United Kingdom |
| Company sponsor | Queen Mary University of London |
| Other ID(s) | 009436QM|2014-000199-25 |
| Vector information | |||
|
|||
| Cohort 1 | |||||
|
|||||